902576-09-4 Usage
Uses
Used in Pharmaceutical Industry:
2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE is used as a potential pharmacophore for the development of new drugs, leveraging its diverse biological activities, including anticancer, antimicrobial, and anti-inflammatory properties. Its unique structure and the range of biological activities it exhibits make it a valuable asset in the search for novel therapeutic agents.
Used in Drug Discovery:
2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE is used as a starting point for drug discovery, where its unique structure and biological activities can be further optimized and modified to create more potent and selective therapeutic agents. 2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE's potential as a pharmacophore makes it a valuable tool in the development of new drugs with improved efficacy and safety profiles.
Used in Anticancer Research:
2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE is used as a research compound in anticancer studies, where its potential to inhibit cancer cell growth and proliferation can be explored. 2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE's anticancer properties may be harnessed to develop new treatments for various types of cancer, improving patient outcomes and offering alternative therapeutic options.
Used in Antimicrobial Applications:
2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE is used as an antimicrobial agent, where its potential to inhibit the growth of bacteria and other microorganisms can be investigated. 2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE may contribute to the development of new antimicrobial drugs to combat drug-resistant infections and improve public health.
Used in Anti-inflammatory Research:
2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE is used in anti-inflammatory research to study its potential to reduce inflammation and alleviate symptoms associated with inflammatory diseases. 2-(METHYLTHIO)PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE's anti-inflammatory properties may lead to the development of new treatments for conditions such as arthritis, asthma, and other inflammatory disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 902576-09-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,2,5,7 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 902576-09:
(8*9)+(7*0)+(6*2)+(5*5)+(4*7)+(3*6)+(2*0)+(1*9)=164
164 % 10 = 4
So 902576-09-4 is a valid CAS Registry Number.
902576-09-4Relevant articles and documents
TAM KINASE INHIBITORS
-
, (2019/02/02)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat diseases, such as cancer.
PYRIDOPYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
-
, (2014/03/21)
Compounds of the formula (I) in which R, R1 and R2 have the meanings indicated in Claim 1, are inhibitors of Syk, and can be employed, inter alia, for the treatment of cancer, rheumatoid arthritis and / or systemic lupus
PYRIDOPYRIMIDINONE INHIBITORS OF KINASES
-
, (2013/09/12)
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, R4, and B are defined in the description. The present invention relates also to compositions cont
2, 5-DIAMINO-SUBSTITUTED PYRIDO [4, 3-D] PYRIMIDINES AS AUTOTAXIN INHIBITORS AGAINST CANCER
-
Page/Page column 89, (2010/06/20)
The present invention relates to pyridopyrimidine derivatives according to formula (I), as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
